Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Prescient logo — See further, go deeper, Deliver impact.

Prescient

See further, go deeper, Deliver impact.

Founded 2007 United Kingdom London, United Kingdom 563 employees Private Equity Biotechnology, Health Care +1

General Information

Company Name Prescient
Founded Year 2007
Location United Kingdom London, United Kingdom
Founders / Decision Makers
Team member Team member
Employees 563
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Private Equity
Business Model B2B
Revenue Model Consulting Fee, Service Fee, Project Based
Offices as of Sep 2026
London, United Kingdom Jersey City, United States Gurgaon, India Chaoyang, China Boston, United States Hale, United Kingdom Barcelona, Spain Ascot, United Kingdom
Social

BounceWatch is an independent company data service, not affiliated with Prescient. To contact Prescient, visit prescienthg.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Prescient compare?

A PDF of Prescient and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Prescient soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Prescient

Prescient, operating under the slogan "See further, go deeper", is a strategic consultancy specializing in bioscience. Established in 2007 and headquartered in the United Kingdom, the company provides integrated, competitive, and customer insight-driven strategies across the full drug lifecycle.

With a focus on biotechnology, healthcare, and pharmaceuticals, Prescient leverages its deep scientific and clinical insights to forge meaningful partnerships in pursuit of transformative innovation. By combining strategic rigor and scientific expertise, the company aims to unlock the full potential of healthcare advancements, ultimately benefiting global health outcomes.

Having become a portfolio company of Bridgepoint Development Capital in 2021 and Baird Capital since 2017, Prescient received its most recent investment during a Private Equity Round on 27 July 2017. These strategic partnerships underscore its commitment to advancing innovation within the industry.

Business keywords: Bioscience Specialists, Strategic Consultancy, Drug Lifecycle, Clinical Insights, Healthcare Innovation, Portfolio Strategy, Competitive Intelligence, Therapeutic Expertise, Oncology, Immunotherapy, Biosimilars, Product Differentiation, Lifecycle Management, Clinical Development Strategy, Value Proposition Development

Services & Products

Competitive Intelligence Programs
Customer Understanding and Insights
Early Asset Strategy Development
Brand Building and Commercialization
Scientific Strategy and Medical Affairs
Market Access Strategies
Portfolio Strategy
Integrated Evidence Planning

Target Customers

Biopharmaceutical Companies Healthcare Organizations Pharmaceutical Executives Patient-Centric Teams

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round Undisclosed 1
Baird Capital
Baird Capital
27 Jul 2017

Prescient Alternatives & Competitors

View All Alternatives
Prescient vs
tranScrip
tranScrip United Kingdom

tranScrip is now part of TMC, a global pharma services company offering end-to-end drug development...

Growth
68 employees
Biotechnology, Health Care
Prescient vs
Avenzo Therapeutics
Avenzo Therapeutics United States

Developing the next generation of oncology therapies for patients

61 employees
Biotechnology, Health Care
Prescient vs
Blueprint Medicines
Blueprint Medicines United States

Striving to improve and extend patients' lives

Acquired
782 employees
Biotechnology, Health Care
View all alternatives

FAQ About Prescient

See further, go deeper, Deliver impact.
Prescient was founded in 2007.
Prescient is headquartered in London, United Kingdom. As of Sep 2026, it also has offices in Jersey City, United States, Gurgaon, India, Chaoyang, China, Boston, United States and Hale, United Kingdom.
Prescient operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Bioscience Specialists, Strategic Consultancy, Drug Lifecycle and Clinical Insights. Its customers include Biopharmaceutical Companies, Healthcare Organizations and Pharmaceutical Executives.
Prescient has a B2B business model. Its revenue comes from Consulting Fee, Service Fee and Project Based.
Prescient has approximately 563 employees.
Prescient has completed 1 funding round. The latest funding stage is Private Equity.
Prescient offers: Competitive Intelligence Programs, Customer Understanding and Insights, Early Asset Strategy Development, Brand Building and Commercialization, Scientific Strategy and Medical Affairs, Market Access Strategies, Portfolio Strategy, Integrated Evidence Planning.
Top alternatives and competitors to Prescient include tranScrip, Avenzo Therapeutics, Blueprint Medicines, Primmune Therapeutics, Celltrion Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prescient and tranScrip are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Prescient, https://bouncewatch.com/company/prescient-1, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout